期刊文献+

MK801对大鼠脑缺血再灌注后海马CA1区c-fos基因表达及神经元凋亡的影响 被引量:3

Effects of MK801 on the Expression of c-fos Gene and the Nerves in Hippocampus CA1 Region After Ischemic-Reperfusion Injury
下载PDF
导出
摘要 目的:研究MK801对大鼠脑缺血再灌注后海马CA1区c-fos基因表达及神经元凋亡的影响。方法:将大鼠随机分为正常对照组、脑缺血再灌注模型组和脑缺血用药后再灌注组,用药组在再灌注前经腹腔注射MK801(0.5mg/kg);分别于再灌注后2、6、24和48 h,采用免疫组化法和Western印迹观察海马CA1区c-fos基因的表达情况。结果:c-fos基因的表达在脑缺血再灌注后2 h即开始增强,至再灌注后6 h达到高峰,24 h表达降低,至48 h又至高峰,但较再灌注6 h后较低。用药组海马CA1区c-fos基因的表达均较模型组的相应时间段降低,具有显著性差异(P<0.01)。结论:海马CA1区c-fos基因在脑缺血再灌注后表达升高,MK801可降低脑缺血再灌注后c-fos基因的表达,对缺血再灌注后的脑组织具有保护作用。 Objective: To observe the effect of MK801 on the expression of c-fos gene and its protective effects on the nerves in the hippocampus CA1 region of the rats after the brain ischemic-reperfussion injury.Methods: The study rats were divided into the control group,the ischemic-reperfussion model group,and the MK801 treated(0.5 mg/kg,i.v.) group.The expression of c-fos gene in the hippocampus CA1 region was measured by immunohistochemistry and Western blotting methods post ischemic-reperfussion at 2,6,24 and 48 h point.Results: The expression of the c-fos gene appeared at 2 h after the brain ischemic-reperfussion and it was up to its maximum 4 h later,then it decreased at 24 h point,at 48 h point it was back up,but lower than the highest point.Compared with the model group,the expression of the c-fos gene was lower than MK801 group at the same time interval.There were statistically significant difference between them(P0.01).Conclusion: MK801 can decrease the expression of the c-fos gene and has the protective effects on the nerves in the hippocampus CA1 region after the ischemic-reperfussion injury.
出处 《生物技术通讯》 CAS 2011年第4期532-535,共4页 Letters in Biotechnology
关键词 脑缺血再灌注 MK801 C-FOS基因 大鼠 brian ischemic-reperfussion injury MK801 c-fos gene rats
  • 相关文献

参考文献7

  • 1李炜如.兴奋性氨基酸及钙离子内流在缺氧缺血性脑损伤中的作用[J].中国实用儿科杂志,1997,12(4):245-246. 被引量:33
  • 2Vornov J J, Tasker R C, CoyleJ T, et al. Delayed protection by MK801 and tetrodotoxin iu rat organtypic hippocampal culture model of ischemia[J]. Stroke, 1994,25:457-461.
  • 3She W, Zhang G, Zhang G. Nuclear factor kappa B activation is mediated by NMDA and non-NMDA receptor and L-type vohagegated Ca2+ channel following severe global ischemia in rat hippocampus[J]. Brain Res. 2002.933(1):23-30.
  • 4安仁哲,申英姬,尹永日,李红子.MK801对缺氧缺血性脑损伤的保护作用[J].延边大学医学学报,2003,26(2):99-101. 被引量:3
  • 5Hess J, Angel P, Schorpp-Kistner M. AP-1 subunits: quarreland harmony among siblings [J].J Cell Sci, 2004,117:5965- 5973.
  • 6McBride K, Charron F, Lefebvre C, et a l. Interaction with GATA transcription factors provides a mechanism tbr cell-specific effects of c-fos[J]. Oncogene, 2003,22:8403-8412.
  • 7Lindwall C, Kanje M. The Janus role of c-Jun: cell death versus survival and regeneration of neonatal sympathetic and ensoryneurons[J]. Exp Neurol, 2005,196(1): 184-194.

二级参考文献2

共引文献34

同被引文献36

  • 1刘存志,于建春,王彤,韩景献.针刺改善多发梗死性痴呆大鼠认知损害的研究[J].中国行为医学科学,2005,14(12):1060-1062. 被引量:42
  • 2脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15750
  • 3朱培俊,安宝富,董小惠.首发偏执型精神分裂症血清NO/NOS水平的研究[J].神经疾病与精神卫生,2007,7(4):260-261. 被引量:1
  • 4Brennand KJ, Landek-Salgado MA, Sawa A. Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells[J]. Bio psyc, 2014, 75(12): 936-944.
  • 5Gurovich IY, Schmukler AB, Storozhakova YA, et al. Depressive symptoms diagnosis and treatment of schizophrenia and schizophrenia spectrum disorders in Russian clinical practice [J]. Zhurnal nevrologii i psikhiatrii imcni S.S. Korsakova, 2013, 113 (11 Pt 2): 28-33.
  • 6Foussias G, Agid O, Fervaha G, et al. Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders [J]. Eur neuropsy, 2014, 24 (5): 693-709.
  • 7Volavka J, Czobor P, Citrome L, et al. Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study[J]. CNS spectrums, 2012, 10(7): 1-8.
  • 8Xiao Y, Lui S, Deng W, et al. Altered Cortical Thickness Related to Clinical Severity But Not the Untreated Disease Duration in Schizophrenia[J]. Schizophrenia bull, 2013, 11 (3): 34-39.
  • 9Tarbox SI, Addington J, Cadenhead KS, et al. Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders[J]. Psychiatry research, 2014, 215(1): 52-60.
  • 10Vaisanen J, Ihalainen J, Tanila H, et al. Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia[J]. Cellular mol neuro, 2004, 24(6): 769-780.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部